Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1985 1
1986 15
1987 28
1988 37
1989 44
1990 42
1991 40
1992 43
1993 47
1994 41
1995 61
1996 54
1997 61
1998 44
1999 46
2000 58
2001 52
2002 42
2003 43
2004 44
2005 38
2006 30
2007 26
2008 35
2009 24
2010 31
2011 31
2012 29
2013 24
2014 23
2015 19
2016 18
2017 15
2018 15
2019 19
2020 41
2021 28
2022 26
2023 17
2024 26
2025 13
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,338 results

Results by year

Filters applied: . Clear all
Page 1
ACE inhibitor-induced cough.
Do TM, Wandres DL, Hart LL. Do TM, et al. DICP. 1990 Nov;24(11):1059-60. doi: 10.1177/106002809002401107. DICP. 1990. PMID: 2275228 Review. No abstract available.
Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis.
Hu Y, Liang L, Liu S, Kung JY, Banh HL. Hu Y, et al. J Clin Hypertens (Greenwich). 2023 Aug;25(8):661-688. doi: 10.1111/jch.14695. Epub 2023 Jul 7. J Clin Hypertens (Greenwich). 2023. PMID: 37417783 Free PMC article.
Studies have shown that angiotensin converting enzyme inhibitors (ACEIs) are superior in primary and secondary prevention for cardiac mortality and morbidity to angiotensin receptor blocker (ARBs). ...All ACEI has the similar risk of developing a co …
Studies have shown that angiotensin converting enzyme inhibitors (ACEIs) are superior in primary and secondary p …
ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management.
Overlack A. Overlack A. Drug Saf. 1996 Jul;15(1):72-8. doi: 10.2165/00002018-199615010-00006. Drug Saf. 1996. PMID: 8862965 Review.
In half of these patients, the ACE inhibitor has to be discontinued. Cough has emerged as a class effect occurring with all ACE inhibitors with no clear difference between the single substances. ...Replacement by another ACE inhibitor …
In half of these patients, the ACE inhibitor has to be discontinued. Cough has emerged as a class effect occurring with …
ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights.
Cutrell S, Alhomoud IS, Mehta A, Talasaz AH, Van Tassell B, Dixon DL. Cutrell S, et al. Curr Hypertens Rep. 2023 Sep;25(9):243-250. doi: 10.1007/s11906-023-01248-2. Epub 2023 Jun 7. Curr Hypertens Rep. 2023. PMID: 37284934 Review.
PURPOSE OF REVIEW: This review describes the discovery and development of ACE inhibitors as antihypertensive agents, compares their efficacy, tolerability, and safety to ARBs, and highlights the contemporary issues surrounding ACE inhibitor use for HTN …
PURPOSE OF REVIEW: This review describes the discovery and development of ACE inhibitors as antihypertensive agents, compares …
ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.
Pylypchuk GB. Pylypchuk GB. Ann Pharmacother. 1998 Oct;32(10):1060-6. doi: 10.1345/aph.17388. Ann Pharmacother. 1998. PMID: 9793599 Review.
OBJECTIVE: To compare the tolerability of angiotensin-converting enzyme (ACE) inhibitors with that of angiotensin II (AII)-receptor blockers and the incidence of cough and angioedema associated with their use through review of published d …
OBJECTIVE: To compare the tolerability of angiotensin-converting enzyme (ACE) inhibitors with that of ang …
Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.
Li YF, Zhu XM, Liu F, Xiao CS, Bian YF, Li H, Cai J, Li RS, Yang XC. Li YF, et al. PLoS One. 2012;7(6):e37396. doi: 10.1371/journal.pone.0037396. Epub 2012 Jun 19. PLoS One. 2012. PMID: 22723835 Free PMC article.
OBJECTIVE: An insertion/deletion (I/D) variant in the angiotensin-converting enzyme (ACE) gene was associated with ACE inhibitor (ACEI)-related cough in previous studies. ...Our objective was to assess the relationship between the …
OBJECTIVE: An insertion/deletion (I/D) variant in the angiotensin-converting enzyme (ACE) gene was associated wi …
Treatment of ACE inhibitor-induced cough.
Luque CA, Vazquez Ortiz M. Luque CA, et al. Pharmacotherapy. 1999 Jul;19(7):804-10. doi: 10.1592/phco.19.10.804.31563. Pharmacotherapy. 1999. PMID: 10417028 Review.
Angiotensin-converting enzyme (ACE) inhibitors are widely administered to treat numerous medical conditions. ...When discontinuing the ACE inhibitor is not an ideal option, pharmacologic treatment of the cough may be conside …
Angiotensin-converting enzyme (ACE) inhibitors are widely administered to treat numerous medical conditio …
Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis.
Mahmoudpour SH, Leusink M, van der Putten L, Terreehorst I, Asselbergs FW, de Boer A, Maitland-van der Zee AH. Mahmoudpour SH, et al. Pharmacogenomics. 2013 Feb;14(3):249-60. doi: 10.2217/pgs.12.206. Pharmacogenomics. 2013. PMID: 23394388
AIM: Angioedema and cough are the two most important adverse effects of ACE inhibitors (ACEIs). Evidence exists that ACEI-related angioedema/cough is partly genetically determined and several genes have been identified to play a role in the development …
AIM: Angioedema and cough are the two most important adverse effects of ACE inhibitors (ACEIs). Evidence exists that AC …
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Messerli FH, et al. J Am Coll Cardiol. 2018 Apr 3;71(13):1474-1482. doi: 10.1016/j.jacc.2018.01.058. J Am Coll Cardiol. 2018. PMID: 29598869 Free article. Review.
Most guidelines for the management of patients with cardiovascular disease recommend angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas angiotensin receptor blockers (ARBs) are merely considered an alternative for …
Most guidelines for the management of patients with cardiovascular disease recommend angiotensin-converting enzyme ( …
ACE inhibitor induced cough.
Ansari KU. Ansari KU. J Assoc Physicians India. 1994 Sep;42(9):730-1. J Assoc Physicians India. 1994. PMID: 7533756 Review. No abstract available.
1,338 results